Yes, heres another one...
Wednesday January 14, 4:01 pm Eastern Time
Company Press Release
AXYS Receives Patents On Proprietary Genes
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan. 14, 1998--AXYS Pharmaceuticals, Inc. (Nasdaq: AXPH - news) today announced that the United States Patent and Trademark Office recently issued to AXYS patents No. 5,686,598 and No. 5,705,380 on two proprietary genes known as TULP 1 and TULP 2.
The company noted that it had demonstrated disease linkages for each of the genes and that a manuscript describing some of the properties of the TULP 1 gene will be published in the February 1998 issue of Nature Genetics.
John P. Walker, chairman and chief executive officer of AXYS, indicated, ''We are delighted to be in a position to announce two patents resulting from our proprietary work in gene identification. While the details of the research are being held pending publication in Nature Genetics next month, among the accomplishments achieved by the research team are identification of gene linkages for two disease states.''
AXYS Pharmaceuticals is a leader in the integration of drug discovery technologies from gene identification through clinical development and is focused on the discovery of small molecule therapeutics. The company has research collaborations with world-class pharmaceutical companies, covering a broad range of therapeutic areas including respiratory, cardiovascular, metabolic, and infectious disease as well as oncology and central nervous system disorders.
Except for the historical information contained herein, this press release contains forward-looking statements that involve risks....... |
